IRWD
IronwoodANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
IRWD vs peer average
80/100
IRWD vs. peer average (A vs. C)
Grade spread
A 3 · B 1 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
EVO is the first available peer comparator.
Similar-sized biopharma candidate from the same sector, but its operating model and pipeline exposure are not directly comparable to LINZESS and apraglutide.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IRWD
Ironwood
EVO
Evotec SE
Grade
A
A
Momentum
38
98
Value
71
41
Sentiment
72
82
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs EVO
IRWD / EVO
Grade Position
Above peers
IRWD vs. peer average (A vs. C)
80/100
Momentum
38
EVOValue
71
IRWDSentiment
72
EVORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IRWD
EVO is the first peer returned for this comparison set.